FDA.reportPublic FDA data

HYPROMELLOSE 2208 (15000 MPA.S)

Substance profile for UNII Z78RG6M2N2, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
Z78RG6M2N2
Preferred term
HYPROMELLOSE 2208 (15000 MPA.S)
Registry number
9004-65-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1300445
PubChem
0
NCIt
C80265
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1300445mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1300445
NCI ThesaurusC80265ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C80265
FDA Substance Registration SystemZ78RG6M2N2precision.fda.gov/uniisearch/srs/unii/Z78RG6M2N2

DailyMed Socrata Ingredients#

Ingredient, Type, DailyMed label table
IngredientTypeDailyMed labelSPL version
hypromellose 2208 (15000 mpa.s)INACTIVE INGREDIENTNatural Vaginal Care2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMETFORMIN HYDROCHLORIDE, USP TABLETS and METFORMIN HYDROCHLORIDE, USP EXTENDED-RELEASE TABLETS2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTb32fcb1b-fee4-44b8-a91c-10dfdd3f84ea3
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use INTUNIV safely and effectively. See full prescribing information for INTUNIV . INTUNIV (guanfacine) extended-release tablets, for oral use Initial U.S. Approval: 1986 ® ® ®4
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19953
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19952
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 19953
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use Fluvastatin Sodium Extended-Release Tablets, USP safely and effectively. See full prescribing information for Fluvastatin Sodium Extended-Release Tablets, USP Fluvastatin Sodium Extended-Release Tablets, USP for oral use Initial U.S. Approval: 1993/ 20005
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use Lescol ® / Lescol ® XL safely and effectively. See full prescribing information for Lescol ® / Lescol ® XL. Lescol ® (fluvastatin sodium) capsules/ Lescol ® XL (fluvastatin sodium) extended-release tablets for oral use Initial U.S. Approval: 1993/ 20002
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, oral Initial U.S. Approval: 20081
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPREMARIN ® (conjugated estrogens tablets, USP)1
Hypromellose 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use XELODA ® safely and effectively. See full prescribing information for XELODA ® . XELODA ® (capecitabine) Tablets, Film Coated for Oral use Initial U.S. Approval: 19983
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts3
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts3
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts3
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMORPHINE SULFATE ER - C-II TABLETS - 15MG, 30MG1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDrug Facts1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use Welchol safely and effectively. See full prescribing information for Welchol. Welchol (colesevelam hydrochloride) Tablet, Film Coated, for Oral Welchol (colesevelam hydrochloride) For Suspension, for Oral Initial U.S. Approval: 20002
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDRUG FACTS1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDRUG FACTS1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDRUG FACTS1
Hypromellose 2208 (15000 MPA.S)INACTIVE INGREDIENT8a023942-01e8-4849-aa3c-1a640ffc7fd37
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTGlycare Acne Gel3
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENT0d466214-78a8-44cd-923c-c286a0f74f661
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPerphenazine Tablets, USP2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENT709031e4-4c20-4ea7-beff-6c459709a4331
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTSprintec ® (norgestimate and ethinyl estradiol tablets) Rx only1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDigozin1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTDrug Fact1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTDrug Fact1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMORPHINE SULFATE EXTENDED-RELEASE TABLETS 15 mg, 30 mg, 60 mg, 100 mg*, 200 mg* CII Rx only *100 and 200 mg for use in opioid tolerant patients only2
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTDrug Fact1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTDrug Fact1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTDrug Fact1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTDrug Fact1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTDrug Facts2
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTPREMARIN ® (conjugated estrogens tablets, USP)1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTXELODA ® (capecitabine) TABLETS1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTd27ca215-001c-411b-893e-a8a6200f364e2
hypromellose 2208 (15000 mpa.s)INACTIVE INGREDIENTTRANDATE ® (labetalol hydrochloride) Tablets4
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTETHAMBUTOL HYDROCHLORIDE TABLETS, USP3
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTThese highlights do not include all the information needed to use Tekturna HCT safely and effectively. See full prescribing information for Tekturna HCT . Tekturna HCT (aliskiren and hydrochlorothiazide) T ablets Initial U.S. Approval: 20083
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3747
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3692
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3690
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3678
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC]3057
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPRISTIQ EXTENDED RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2068
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTCETIRIZINE HCL AND PSEUDOEPHEDRINE HCL ER (CETIRIZINE HCL AND PSEUDOEPHEDRINE HCL) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK]1000
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTETHAMBUTOL HYDROCHLORIDE (ETHAMBUTOL HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ]84
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDIGOXIN TABLET [REMEDYREPACK INC. ]47
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]47
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMETHYLPHENIDATE HYDROCHLORIDE TABLET METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.]29
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTINTUNIV (GUANFACINE) TABLET, EXTENDED RELEASE INTUNIV (GUANFACINE) KIT [SHIRE US MANUFACTURING INC.]27
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPREMPHASE (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE) KIT PREMPRO (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]22
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPREMARIN (ESTROGENS, CONJUGATED) TABLET, FILM COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.]21
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTAMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [MAJOR PHARMACEUTICALS]20
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMORPHINE SULFATE TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.]19
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTSINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS LLC]12
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTCIPROFLOXACIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.]11
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMETFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]11
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMETFORMIN HYDROCHLORIDE TABLET, FILM COATED METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [WATSON PHARMA, INC.]11
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTLESCOL (FLUVASTATIN SODIUM) CAPSULE LESCOL XL (FLUVASTATIN SODIUM) TABLET, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION]10
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [CARDINAL HEALTH]10
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTMETOPROLOL TARTRATE TABLET, FILM COATED [MAJOR PHARMACEUTICALS]9
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTPREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [CARDINAL HEALTH]9
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTLEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE]8
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMINOCYCLINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [SANDOZ INC]8
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTCIPROFLOXACIN TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.]7
hypromellose 2208 (15000 mpa.s)INACTIVE INGREDIENTKOMBIGLYZE XR (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [E.R. SQUIBB & SONS, L.L.C.]7
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTLEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.]7
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTETODOLAC TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]6
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTLABETALOL HYDROCHLORIDE TABLET [MAJOR PHARMACEUTICALS]6
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTSTARLIX (NATEGLINIDE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION]6
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTDIGOXIN TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.]5
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTJOLESSA (LEVONORGESTREL / ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.]5
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTLIDOCAINE HYDROCHLORIDE JELLY [HI-TECH PHARMACAL CO., INC.]5
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMETFORMIN HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GOLDEN STATE MEDICAL SUPPLY, INC.]5
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTSITAVIG (ACYCLOVIR) TABLET, DELAYED RELEASE [CIPHER PHARMACEUTICALS US LLC]5
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTFAMOTIDINE TABLET, FILM COATED [MAJOR PHARMACEUTICALS]4
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTLABETALOL HYDROCHLORIDE TABLET [CARDINAL HEALTH]4
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTPERIO GS (HYDROCOTYLE ASIATICA, ECHINACEA PURPUREA, AND SAMBUCUS NIGRA FLOWER) GEL [IZUN PHARMACEUTICALS CORPORATION]4
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTKAPVAY (CLONIDINE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]3
hypromellose 2208 (15000 mpa.s)INACTIVE INGREDIENTKOMBIGLYZE XR (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ASTRAZENECA PHARMACEUTICALS LP]3
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTOMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [KAISER FOUNDATION HOSPITALS]3
HYPROMELLOSE 2208 (15000 MPA.S)ACTIVE INGREDIENTVISCO SHIELD LUBRICANT (HYPROMELLOSE 2208 (15000 MPA.S)) SOLUTION/ DROPS [OASIS MEDICAL, INC.]3
HYPROMELLOSE 2208 (15000 MPA.S)ACTIVE MOIETYVISCO SHIELD LUBRICANT (HYPROMELLOSE 2208 (15000 MPA.S)) SOLUTION/ DROPS [OASIS MEDICAL, INC.]3
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTCLONIDINE HYDROCHLORIDE EXTENDED-RELEASE (CLONIDINE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.]2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTEPLERENONE (EPLERENONE ) TABLET [APOTEX CORP]2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTETODOLAC TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT]2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTFELODIPINE TABLET, EXTENDED RELEASE [HERITAGE PHARMACEUTICALS INC.]2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTFLUVOXAMINE MALEATE TABLET, FILM COATED [BRYANT RANCH PREPACK]2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTLEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, EXTENDED RELEASE [GOLDEN STATE MEDICAL SUPPLY, INC.]2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTMORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [BRYANT RANCH PREPACK]2
hypromellose 2208 (15000 mpa.s)INACTIVE INGREDIENTQUINIDINE GLUCONATE TABLET, EXTENDED RELEASE [RICHMOND PHARMACEUTICALS, INC.]2
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTCEFPROZIL TABLET, FILM COATED [APOTEX CORP]1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTCIPROFLOXACIN (CIPROFLOXACIN) TABLET, FILM COATED [AVKARE, INC.]1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTERY-TAB (ERYTHROMYCIN) TABLET [REMEDYREPACK INC. ]1
HYPROMELLOSE 2208 (15000 CPS)INACTIVE INGREDIENTERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS]1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTETHAMBUTOL HYDROCHLORIDE TABLET [REMEDYREPACK INC. ]1
HYPROMELLOSE 2208 (15000 MPA.S)INACTIVE INGREDIENTFLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE ) TABLET [REMEDYREPACK INC. ]1
HYPROMELLOSE 2208 (15000 MPA.S)ACTIVE INGREDIENTIMPROVUE (HYPROMELLOSE 2208 (15000 MPA.S)) SOLUTION/ DROPS [OCULUS SURGICAL, INC.]1
HYPROMELLOSE 2208 (15000 MPA.S)ACTIVE MOIETYIMPROVUE (HYPROMELLOSE 2208 (15000 MPA.S)) SOLUTION/ DROPS [OCULUS SURGICAL, INC.]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII Z78RG6M2N2 page 1 of 1 · 6 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
HYPROMELLOSE 2208 (15000 MPA.S)Z78RG6M2N29004653TABLETBUCCAL17 mg
HYPROMELLOSE 2208 (15000 MPA.S)Z78RG6M2N29004653CAPSULEORAL80.25 mg
HYPROMELLOSE 2208 (15000 MPA.S)Z78RG6M2N29004653CAPSULE, DELAYED RELEASEORAL222 mg
HYPROMELLOSE 2208 (15000 MPA.S)Z78RG6M2N29004653TABLETORAL375 mg
HYPROMELLOSE 2208 (15000 MPA.S)Z78RG6M2N29004653TABLET, EXTENDED RELEASEORAL4050 mg
HYPROMELLOSE 2208 (15000 MPA.S)Z78RG6M2N29004653TABLET, FILM COATED, EXTENDED RELEASEORAL2640 mg